Asepsis Medical Technologies announces the USPTO issuance of Patent Number U.S. Patent 9,433,726 for its Safe-T-Fuse™ drug infusion system. The Safe-T-Fuse™ is an industry unique infusion container th
Asepsis Medical Technologies announces the Notice of Allowance of Australian Patent Application 2013222819
Asepsis Medical Technologies announces the Notice of Allowance of Australian Patent Application 2013222819 for its Safe-T-Dose® combinatorial drug injection kit. The Asepsis’ Calibrated Drug Delivery™
Asepsis Medical Technologies announces the USPTO grant of Patent Application 14/059,070
Asepsis Medical Technologies announces the USPTO grant of Patent Application 14/059,070 for its Safe-T-Fuse™ drug infusion system. The Safe-T-Fuse™ is an industry unique infusion container that allows
Asepsis announces the USPTO grant of US Patent 9,302,050 for its combinatorial, Calibrated Drug Delivery™ (CDD) platform
Asepsis announces the USPTO grant of U.S. Patent 9,302,050 for its combinatorial, Calibrated Drug Delivery™ (CDD) platform. The 050 patent continuation further enhances the reconstitution aspects of t
Independent formative usability studies were completed on the Asepsis pediatric Calibrated Drug Delivery™ Kits in Chicago, Illinois
Independent formative usability studies were completed on the Asepsis pediatric Calibrated Drug Delivery™ Kits in Chicago, Illinois. The ANSI/AAMI HIE75:2009 and ANSI/AAMI/IEC 62366:2007 studies were